Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis

Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis

ObjectiveThe primary objective of this study was to examine the levels of serum EZH2 in patients diagnosed with bladder cancer, and subsequently evaluate its potential as a biomarker for both the diagnosis and prognosis of bladder cancer.MethodsBlood samples were obtained from 115 bladder cancer pat...

Full description

Bibliographic Details
Main Authors:	Feng Li, Pengqiao Wang, Jun Ye, Guoping Xie, Jinfeng Yang, Wei Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Oncology
Subjects:	EZH2 biomarker bladder cancer diagnosis overall survival rate progression-free survival rate
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1303918/full

Similar Items

A Cohort Study of the Prognostic Impact of Exon-16 EZH2 Mutations in a Mexican-Mestizo Population of Patients with Diffuse Large B-Cell Lymphoma
by: Luis F. Oñate-Ocaña, et al.
Published: (2021-01-01)

Anticancer effects of disulfiram: a systematic review of in vitro, animal, and human studies
by: Ling Wang, et al.
Published: (2022-06-01)

Comprehensive Analysis of the Expression Characteristics of the Enhancer of the Zeste Homolog 2 Gene in Pan-Cancer
by: Yuanyuan Kang, et al.
Published: (2021-07-01)

Biomarkers of related driver genes predict anti-tumor efficacy of immune checkpoint inhibitors
by: Shuai Jiang, et al.
Published: (2022-09-01)

Association between Adverse Events and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study
by: Shigeo Shimose, et al.
Published: (2022-09-01)

Preoperative Fibrinogen–Albumin Ratio, Potential Prognostic Factors for Bladder Cancer Patients Undergoing Radical Cystectomy: A Two-Center Study
by: Chen J, et al.
Published: (2021-04-01)

Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial
by: Ilaria Saltarella, et al.
Published: (2019-01-01)

Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy
by: Zichen Bian, et al.
Published: (2023-01-01)

Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer
by: Zheng Liu, et al.
Published: (2018-09-01)

Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor Prognosis
by: Sebastian C. B. Bremer, et al.
Published: (2022-06-01)

Development and validation of a prognostic nomogram model incorporating routine laboratory biomarkers for preoperative patients with endometrial cancer
by: Rong Cong, et al.
Published: (2023-11-01)

Small RNA sequencing identified miR-3180 as a potential prognostic biomarker for Chinese hepatocellular carcinoma patients
by: Libo Sun, et al.
Published: (2023-03-01)

Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299
by: Arkadiusz Z. Dudek, MD, PhD, et al.
Published: (2023-12-01)

Serum lactate dehydrogenase level predicts the prognosis in bladder cancer patients
by: Shuo Gu, et al.
Published: (2023-04-01)

Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma
by: Manasi Sheth, et al.
Published: (2021-01-01)

Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer
by: Xiangyu Zhang, et al.
Published: (2022-07-01)

Clinical Characteristics, Course, and Long-Term Outcomes in Patients with Talaromyces marneffei Infection: A 10-Year Retrospective Cohort Study
by: QingLiang Yu, et al.
Published: (2023-04-01)

Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer
by: Giuseppe Fallara, et al.
Published: (2023-06-01)

The Predictive Role of Serum Levels of Soluble Cell Adhesion Molecules (sCAMs) in the Therapy of Advanced Breast Cancer—A Single-Centre Study
by: Weronika Bulska-Będkowska, et al.
Published: (2022-01-01)

Microwave ablation plus camrelizumab monotherapy or combination therapy in non-small cell lung cancer
by: Yahan Huang, et al.
Published: (2022-08-01)

Minimally invasive versus open radical trachelectomy for early-stage cervical cancer: protocol for a multicenter randomized controlled trial in China
by: Xiaopei Chao, et al.
Published: (2020-12-01)

Prognostic Significance of Inflammatory Biomarkers in Patients with Breast Cancer Skeletal Metastases
by: Wang Y, et al.
Published: (2020-11-01)

Efficacy and Safety Evaluation of Sintilimab for Cancer Treatment: A Systematic Review and Meta-analysis of Randomized Controlled Trials
by: Ziqi Ye, et al.
Published: (2022-04-01)

Circulating tumor cells as a potential biomarker for postoperative clinical outcome in HBV-related hepatocellular carcinoma
by: Ye X, et al.
Published: (2018-11-01)

Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors
by: Hye Ryeon Kim, et al.
Published: (2022-07-01)

Influence of lymphadenectomy on survival and recurrence in patients with early-stage epithelial ovarian cancer: a meta-analysis
by: Chenchen Yang, et al.
Published: (2023-09-01)

Efficacy and safety of olaparib in advanced ovarian cancer: a meta-analysis
by: Yuanyuan Yang, et al.
Published: (2023-12-01)

The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis
by: Chunmei Zhang, et al.
Published: (2022-08-01)

From clinical trials to the front line: Vinflunine for Treatment of UrothelialCell Carcinoma at the National Cancer Institute of Naples
by: GAETANO eFACCHINI, et al.
Published: (2016-05-01)

The Role of Circulating Tumor Cells in the Prognosis of Metastatic Triple-Negative Breast Cancers: A Systematic Review of the Literature
by: Lorena Alexandra Lisencu, et al.
Published: (2022-03-01)

Impact of probiotics use on clinical outcomes of immune checkpoint inhibitors therapy in cancer patients
by: Luying Wan, et al.
Published: (2023-01-01)

Prognostic role of plasma vitamin D and its association with disease characteristics in germ cell tumours
by: Peter Lesko, et al.
Published: (2023-04-01)

Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma
by: Rishaan Pawaskar, et al.
Published: (2024-02-01)

Outcomes of intravesical Bacillus Calmette-Guerin in patients with non-muscle invasive bladder cancer: a retrospective study in Australia
by: Chamodi Pillippu Hewa, et al.
Published: (2024-02-01)

The diagnostic and prognostic values of circulating miRNA-1246 in multiple myeloma
by: Guimin Zhao, et al.
Published: (2022-12-01)

Potential impact of platelet-to-lymphocyte ratio on prognosis in patients with colorectal cancer: A systematic review and meta-analysis
by: Ganlin Guo, et al.
Published: (2023-03-01)

The Immune Cell Infiltration Patterns and Characterization Score in Bladder Cancer to Identify Prognosis
by: Yongsheng Zhang, et al.
Published: (2022-06-01)

Association Between Endometriosis and Prognosis of Ovarian Cancer: An Updated Meta-Analysis
by: Peng Chen, et al.
Published: (2022-03-01)

Management of Recurrent Meningiomas: State of the Art and Perspectives
by: Marco Vincenzo Corniola, et al.
Published: (2022-08-01)

Bevacizumab with Chemotherapy as a First-Line Treatment for Advanced Ovarian Cancer in a Serbian Cohort
by: Irena Conic, et al.
Published: (2022-04-01)